Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma (Q36592481)

15 August 2017

1 reference

title

Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma (English)

1 reference

15 August 2017

L M Rainwater

1 reference

15 August 2017

W R Morgan

series ordinal

1 reference

15 August 2017

G G Klee

series ordinal

1 reference

15 August 2017

H Zincke

series ordinal

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 1990

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

1118-1126

1 reference

Of historical interest. General Grant fights cancer

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Clinical significance of the human acid phosphatases: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Serum prostatic acid phosphatase and cancer of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Electrophoretic characterization of the prostate. I. Proteins and lactic dehydrogenase in benign hyperplasia and carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Alterations in Serum Lactate Dehydrogenase and its Fourth and Fifth Isozymes in Patients with Prostatic Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Multiple Immunoperoxidase Markers in Benign Hyperplasia and Adenocarcinoma of the Prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Monoclonal antibody (anti-Leu 7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Three predominant proteins secreted by the human prostate gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Studies on the antigenic properties of prostatic tissue. I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Immunologic studies of normal, benign, and malignant human prostatic tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Prostate antigen: A new potential marker for prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Differences in values obtained with 2 assays of prostate specific antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Evaluation of specific antigen and prostatic acid phosphatase specificity. Study of false values

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

The role of prostate specific antigen in the baseline assessment of patients undergoing hormone therapy for advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

An evaluation of prostate specific antigen in prostatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Pre-Treatment and Post-Treatment Evaluation of Prostatic Adenocarcinoma for Prostatic Specific Acid Phosphatase and Prostatic Specific Antigen by Immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Changes in immunohistochemical staining in prostatic adenocarcinoma following diethylstilbestrol therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Biochemical monitoring of carcinoma of prostate treated with an LH-RH analogue (Zoladex)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Early detection of prostate cancer by routine screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962725-6

10.1016/S0025-6196(12)62725-6

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference